
Datwyler focuses on high-value, system-critical elastomer components organized in Healthcare and Industrial divisions.
datwyler.comCrawled Nov 19, 2026
Datwyler provides parenteral drug packaging solutions to pharmaceutical and biotech companies globally, aiming to create a safe healthcare environment.
Datwyler medical packaging improves patient lives by offering advanced parenteral drug solutions to global pharmaceutical and biotech firms, ensuring safety and reliability.
Datwyler’s industrial sealing solutions combine custom engineering, material expertise, and global manufacturing for demanding applications.
Datwyler develops system-critical sealing technologies for reliable, high-quality mobility solutions.
In the fast-evolving landscape of global electrification and smart electronics, saying ahead requires more than just high-quality components — it requires deep material science and application expertise.
The Battery Show North America 2026 Dates: October 12–15, 2026 Location: Huntington Place, Detroit, MI Booth: #5038
IATF 16949:2016 IATF #0581529 Cleebronn, DE
Explore Datwyler Media for the latest news, press releases, events, publications and downloadable media resources.
The page provides information on Datwyler’s product development, sustainability reports, and media releases.
Discover the latest news, media and ad hoc announcements, as well as articles and updates on our technologies and solutions.
The magazine Rubber World writes in an article about the newly launched NeoFlex plungers for large-volume auto-injectors and wearable devices.
The page lists job opportunities at Datwyler and highlights the company as an employer.
…and our employees as the keys to our success. Our employees are at the heart of our corporate culture. We all work in concert – day after day to achieve the best outcomes and with a shared self-image of our actions. Every employee is part of our success story. Every employee contributes to success with […]
The page lists job opportunities and career paths at Dätwyler.
Dr. Paul Hälg joined Dätwyler Holding Inc. as Chairman in 2017. He previously served as CEO from 2004 to 2016 and remains on the Board of Directors of Datwyler IT Infra AG.
The page introduces Datwyler’s Executive Committee and the executives leading the company and its divisions.
With these combined capabilities, we create cutting-edge solutions that enable our partners to turn the challenges of today into the achievements of tomorrow. Engineering. Material & simulation expertise. Processing quality. Global services.
Our core competencies allow us to deliver superior customer value by taking innovative ideas from prototype to efficient serial production. This generates clear advantages for our customers throughout the entire life cycle of their products.
Information for Datwyler investors, including financial reports, key figures, share information and events.
The page provides contact information for Datwyler’s products, solutions, services, and company inquiries.
As an expert development partner and experienced industrial company, it is particularly important to us to provide the fastest possible service and to maintain direct dialog between our customers and our experts.
The page provides contact information for Datwyler’s products and solutions.
Complete the form to access the resource.
Leading provider of high-quality, system-critical elastomer components in Healthcare, Transportation & Electronics, General Industry and Food & Beverage.
The page presents Datwyler’s General Terms and Conditions for Distribution, which govern collaboration with customers by region.
On this page, you will find our Terms and Conditions for Supply, which form the basis for the collaboration with our customers. Please ensure that you review the terms applicable to your respective region.
On this page, you will find our Purchasing Terms and Conditions, which form the basis for our collaboration with suppliers. Please ensure that you review the terms carefully.
Datwyler reports **CHF 582.7 million in net revenue for H1 2026**, a 4.6% organic increase over the prior-year period. The company’s **Healthcare division** drives growth, while **Industrial division** faces challenges from weak end-markets and geopolitical headwinds. Organic expansion highlights progress in its strategic transformation.
Datwyler appoints Cindy Reiss-Clark as Chief Operating Officer (COO) of its Healthcare Division, effective April 7, 2026. The company restructures its Executive Board to enhance organizational focus and drive future growth. Datwyler specializes in supplying critical high-tech components for industrial applications. The realignment aims to strengthen customer-centric innovation strategies.
Datwyler’s 68th Annual General Meeting, held in Altdorf on March 17, 2026, saw shareholders approve all Board proposals with **87.42% of voting shares represented** (30.2 million votes). The meeting highlights the company’s **stable dividend policy**, supported by its **solid free cash flow** performance.
Dätwyler acquires a majority stake in Capsul’in, expanding its portfolio of high-tech components. The move strengthens the company’s position in specialized manufacturing solutions. No further details on the transaction size or terms are disclosed.
Datwyler acquires a majority stake in **Capsul’in** to expand its **Food & Beverage** business. The move targets structurally growing, low-cyclical market segments with steady customer demand. The transaction aligns with Datwyler’s strategy of scaling high-tech components in high-growth sectors.
Datwyler reports **CHF 1.1 billion in revenue** for 2025, with **3.1% organic growth** after adjusting for a **3.7% negative currency impact**. The Healthcare division shows strong performance, while the company’s *ForwardNow* transformation program delivers early contributions. Reported revenue declines **0.6% year-over-year** due to currency headwinds.